International Journal of Hematology

, Volume 107, Issue 4, pp 436–441 | Cite as

Genetic analysis of a novel missense mutation (Gly542Ser) with factor XII deficiency in a Chinese patient of consanguineous marriage

  • Anqing Zou
  • Mingshan Wang
  • Yanhui Jin
  • Xiaoli Cheng
  • Kankan Su
  • Lihong Yang
Original Article


Coagulation factor XII deficiency is a rare autosomal recessive disorder, which could be found in a consanguineous family. We studied a Chinese family in which the activated partial thromboplastin time (APTT) of the proband had clearly prolonged up to 101.7 s, associated with low FXII activity of 3% and FXII antigen < 1%. To analyze the gene mutation in this FXII-deficient patient, we performed FXII mutation screening, and analyzed the DNA sequence of the F12 gene. A ClustalX-2.1-win and four online bioinformatics software services were used to study the conservatism and effects of the mutation. A transient in vitro expression study was performed to elucidate the possible pathological mechanism. Sequence analysis revealed a homozygous c.1681 G > A point mutation in exon 14, causing a novel Gly542Ser mutation in the catalytic domain. The results of the conservatism and bioinformatics analyses both indicated that the mutation likely affects the function of the protein. Additional expression studies in COS-7 cells showed that the antigen level of mutant FXII (FXII-Gly542Ser) was lower than wild type in culture medium, whereas the corresponding level of FXII antigen in cell lysates was equivalent. These results suggest that the Gly542Ser mutation causes FXII deficiency through intracellular degradation.


Gene mutation Factor XII deficiency Genetic analysis CRM Expression study 



We thank all the participants in this study.

Compliance with ethical standards

Conflict of interests

No potential conflict of interest was reported by the authors.


  1. 1.
    Citarella F, Ravon DM, Pascucci B, Felici A, Fantoni A, Hack CE. Structure/function analysis of human factor XII using recombinant deletion mutants. Eur J Biochem. 1996;238:240–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Ishii K, Oguchi S, Moriki T, Yatabe Y, Takeshita E, Murata M, et al. Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency. Blood Coagul Fibrin. 2004;15:367–73.CrossRefGoogle Scholar
  3. 3.
    Kaplan AP, Silverberg M. The coagulation-kinin pathway of human plasma. Blood. 1987;70:1–15.PubMedGoogle Scholar
  4. 4.
    McMullen BA, Fujikawa K. Amino acid sequence of the heavy chain of human a-factor XIIa (activated hageman factor). J Biol Chem. 1985;260:5328–41.PubMedGoogle Scholar
  5. 5.
    Iijima K, Arakawa Y, Sugahara Y, Matsushita M, Moriguchi Y, Shimohiro H, et al. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity. Thromb Haemost. 2011;105:473–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Pauer HU, Burfeind P, Köstering H, Emons G, Hinney B. Factor XII deficiency is strongly associated with primary recurrent abortions. Fertil Steril. 2003;80:590–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Mordillo C, Martinez-Marchαn E, Fontcuberta J, Soria JM. Molecular analysis of multiple genetic variants in Spanish FXII-deficient families. Haematologica. 2007;92:1569–72.CrossRefPubMedGoogle Scholar
  8. 8.
    Renné T, Schmaier AH, Nickel KF, Blombäck M, Maas C. In vivo roles of factor XII. Blood. 2012;120(22):4296–303.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Singhamatr P, Kanjanapongkul S, Rojnuckarin P. Molecular analysis of factor XII gene in Thai patients with factor XII deficiency. Blood Coagul Fibrinolysis. 2013;24:599–604.CrossRefPubMedGoogle Scholar
  10. 10.
    Ishii K, Oguchi S, Moriki T, Yatabe Y, Takeshita E, Murata M, et al. Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency. Blood Coagul Fibrinolysis. 2004;15:367–73.CrossRefPubMedGoogle Scholar
  11. 11.
    Suzuki K, Murai K, Suwabe A, Ishida Y. Factor XII Ofunato: Lys346Asn mutation associated with blood coagulation factor XII deficiency causes impaired secretion through a proteasome-mediated degradation. Thromb Res. 2010;125:438–43.CrossRefPubMedGoogle Scholar
  12. 12.
    Yang LH, Wang YY, Zhou JP, Cheng XL, Hao XP, Xie HX, et al. Identification of genetic defects underlying FXII deficiency in four unrelated Chinese patients. Acta Haematol. 2016;135:238–40.CrossRefPubMedGoogle Scholar
  13. 13.
    Dai LY, Zhang DT, Lin J, Wang YY, Tong Y, Li J, et al. A pedigree analysis of Hereditary coagulation factor XII deficiency caused by a novel homozygous mutation: Leu519Arg. Chin J Lab Med. 2015;38:466–9 (China).Google Scholar
  14. 14.
    Li M, Xie HX, Wang MS, Ding HX. Molecular characterization of a novel missense mutation (Asp538Asn) in a Chinese patient with factor XII deficiency. Clin Lab. 2015;61:1967–71.PubMedGoogle Scholar
  15. 15.
    Miyata T, Kawabata S, Iwanaga S, Takahashi I, Alving B, Saito H. Coagulation factor XII (Hageman factor) Washington DC: inactive factor XIIa results from Cys-571-Ser substitution. Proc Natl Acad Sci USA. 1989;86:8319–22.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Kondo S, Tokunaga F, Kawano S, Oono Y, Kumagai S, Koide T. Factor XII Tenri, a novel cross-reacting material negative factor XII deficiency, occurs through a proteasome-mediated degradation. Blood. 1999;93:4300–8.PubMedGoogle Scholar
  17. 17.
    Matsuki E, Miyakawa Y, Okamoto S. A novel factor XII mutation, FXII R84P, causing factor XII deficiency in a patient with hereditary spastic paraplegia. Blood Coagul Fibrinolysis. 2011;22:227–30.CrossRefPubMedGoogle Scholar
  18. 18.
    Yarovaya GA, Blokhina TB, Neshkova EA. Contact system. New concepts on activation mechanisms and bioregulatory functions. Biochemistry. 2002;67:13–24.PubMedGoogle Scholar
  19. 19.
    Wang XF, Dai J, Wang MS, Ding QL, Wang HL. Analysis of the factor XII gene mutations in two Chinese pedigrees with congenital clotting factor XII deficiency. J Diagn Concepts Pract. 2005;4:447–50 (Shanghai).Google Scholar

Copyright information

© The Japanese Society of Hematology 2018

Authors and Affiliations

  1. 1.Department of Clinical LaboratoryThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhouChina

Personalised recommendations